Iomai Corporation
Iomai Corporation discovers and develops vaccines and immune system stimulants, delivered via a novel, needle-free technology called.
Employees
Enterprise value
$216—324m
loading funding rounds…
Essex Woodlands Health Ventures(exited)
MedImmune Ventures(exited)
NEA(exited)
EW Healthcare Partners(exited)
Red Abbey Venture Partners(exited)
Related Content
Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads
Tech stack
Tech stackLearn more about the technologies and tools that this company uses.